Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Management of thin gingival phenotype using non-surgical methods (injection of liquid platelet rich fibrin and exposure to low level laser therapy
Thin gingival phenotype can lead to recession and root exposure. Liquid prf can be obtained by centrifugion of blood sample on speed 700 rpm for 3 min, then injection of this liquid in the attached gingiva and muco-gingival junction (3 times with 7 days interval) for the first group. The second group will be injected with I-PRF in the same method in addition to exposure to Low Level Laser therapy (after each injection of I-PRF). This method is expected to increase the thickness of the gingiva.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Test group: injectable platelet rich fibrin+ low level laser therapy | Active Comparator | patients with thin gingival phenotype (gingival thickness less than 1mm) recieve I-PRF+LLLT radiation just after the injection for 3 sessions with 7 days interval between the sessions. |
|
| Control group :I-PRF group | Active Comparator | patients with thin gingival phenotype received I-PRF alone in 3 sessions, with 7 days interval between the sessions. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Biologic Agent: injectable platelet rich fibrin. | Biological | injection of I-PRF to thin gingival phenotype 3 times with 7 days interval between sessions. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Gingival thickness improvement in millimeters. | clinical parameter | 6 months after treatment |
| Keratinized tissue width improvement in millimeters. | Clinincal parameter. | 6 months after treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Improvement of gingival index. | Clinical parameter. | 6 months after treatment |
| Improvement of bleeding on probing. | Clinical parameter. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ahmed Eldawy, doctor | MINDRAY | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Alaa Elsayed | Cairo | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010510 | Periodontal Diseases |
| ID | Term |
|---|---|
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
Not provided
Not provided
group1: received I-PRF alone, and group 2: received I-PRF+LLLT
Not provided
Not provided
I-PRF biologic product
|
| injecable platelet rich fibrin, and low level laser therapy radiation. | Other | injection of I-PRF+ exposure to LLLT to thin gingival phenotype 3 times with 7 days interval between sessions. |
|
| 6 months after treatment |
| Improvement of sulcus depth. | Clinical parameter. | 6 months after treatment |